Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 3 (2021) History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization Abstract  similar documents
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov
"... trials (CT) and randomized controlled trials (RCT), and the inclusion of these approaches in health ..."
 
Vol 14, No 4 (2021) History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals Abstract  similar documents
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov
"... , controlled trials (CT) and randomized controlled trials (RCT), and the inclusion of these approaches ..."
 
Vol 14, No 1 (2021) History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources Abstract  similar documents
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov
"... , controlled trials (CT) and randomized controlled trials (RCT), and the inclusion of these experimental ..."
 
Vol 12, No 1 (2019) Efficacy of photodynamic therapy in treatment of adult patients with skin cancer Abstract  similar documents
O. V. Kirsanova
"... and methods. We evaluated the data of meta-analyses, results of randomized controlled trials (RCTs ..."
 
Vol 16, No 3 (2023) An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis Abstract  similar documents
M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova
"... ® in the treatment of nonalcoholic fatty liver disease (NAFLD) in a clinical trial. Material and methods. The study ..."
 
Vol 5, No 3 (2012) SEARCH OF INFORMATION IN PHARMACOECONOMIC RESEARCH Abstract  similar documents
R. I. Yagudina, I. V. Novikov, V. G. Serpik
 
Vol 13, No 4 (2020) Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard Abstract  similar documents
I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova
"... Aim. A meta-analysis of 8 controlled studies (n=771, age 53.6±6.2 years) of tie use of tie ..."
 
Vol 8, No 2 (2015) SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS Abstract  similar documents
Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii
"... controlled trials (RCT) EXAMINE, SAVOR-TIMI 53 and TECOS. Conclusion. There were no differences in efficacy ..."
 
Vol 8, No 4 (2015) CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS Abstract  similar documents
E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
"... of randomized controlled trials (RCT) and indirect RCT comparison. The expenditures for drugs of TRA group ..."
 
Vol 7, No 1 (2014) ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY Abstract  similar documents
T. L. Galankin, A. S. Kolbin
"... in post-marketing drug research by the example of large simple trials. ..."
 
Vol 18, No 1 (2025) Trends in the industry of clinical trials Abstract  similar documents
S. S. Milovanov, V. V. Popov, N. V. Teplova
"... Background. The clinical trial (CT) industry is subject to changes, some of which are rapidly ..."
 
Vol 15, No 1 (2022) Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update Abstract  similar documents
V. D. Sokolova, N. A. Sableva, V. V. Mladov, D. G. Tolkacheva
"... trials (RCTs) on a new interleukin (IL) 23 inhibitor registered in the Russian Federation – risankizumab ..."
 
Vol 10, No 1 (2017) PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM Abstract  similar documents
N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova
"... multicenter controlled randomized (phase III) international clinical trials in patients over 12 years of age ..."
 
Vol 9, No 1 (2016) PROSPECTS FOR THE USE OF METHODS OF ECONOMIC EVALUATION AT THE STAGE OF PLANNING AND ORGANISATION OF CLINICAL TRIALS Abstract  similar documents
N. Z. Musina, V. V. Tarasov
"... and organization of clinical trials and considers the examples of studies which undertook this approach. The use ..."
 
Vol 17, No 1 (2024) Changes in patient recruitment parameters and their derivatives under the influence of external factors – population size and density of residence in a certain area Abstract  similar documents
S. S. Milovanov
"... Background. The lack of targeted patient recruitment for clinical trials reaches 90%, which leads ..."
 
Vol 15, No 4 (2022) Historical milestones of the invention and use of placebo Abstract  similar documents
A. N. Koterov
"... into controlled trials, but also with the current popularity of alternative and even esoteric medicine methods ..."
 
Vol 9, No 1 (2016) SYSTEMATIC REVIEW OF PENTAGLOBIN EFFICACY IN PREVENTING MORTALITY IN NEWBORNS AND OLDER CHILDREN WITH BACTERIAL INFECTIONS AND SEPSIS Abstract  similar documents
V. K. Fedyaeva, O. Yu. Rebrova
"... comparison was carried out. Results. Three meta-analyses and 7RCTs were considered, including 6 trials ..."
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov
"... (controlled release tablets tamsulosin 0.4 mg + solifenacin 6 mg) for treatment of patients with storage ..."
 
Vol 14, No 3 (2021) Modern achievements in pharmacotherapy of osteoarthritis based on endo- and phenotyping Abstract  similar documents
I. V. Sarvilina, O. A. Shavlovskaya, O. A. Gromova, A. V. Naumov, M. N. Sharov, Yu. S. Prokofyeva
"... advances in pharmacotherapy of the disease based on data from selected randomized controlled trials ..."
 
Vol 9, No 3 (2016) EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS Abstract  similar documents
N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova
"... of the life cycle of medical technology. This method allows us to optimize the design of clinical trials ..."
 
Vol 15, No 1 (2022) The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 Abstract  similar documents
I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova
"... market of the Samara Region in 2015–2020 was carried out. The material of this retrospective study ..."
 
Vol 15, No 1 (2022) A systematic review of real-world clinical practice data in COVID-19: non-interventional studies Abstract  similar documents
S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov
"... designs of non-interventional real-world clinical practice trials that provide evidence for the efficacy ..."
 
Online First Osteoarthritis therapy misconcepts Abstract  similar documents
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov
"... , including data on adverse events. At last, new randomized controlled trials results, new methods ..."
 
Vol 16, No 2 (2023) From misconceptions to reasonable osteoarthritis patients therapy Abstract  similar documents
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov
"... , new randomized controlled trials results, new methods of adjunctive therapy become available. OA ..."
 
Vol 15, No 2 (2022) Current opportunities for the export of medical services in Russia Abstract  similar documents
S. V. Russkikh, E. A. Tarasenko, S. I. Grin, M. T. Yugay, K. K. Kryukova, L. I. Moskvicheva
"... with 8 high-level healthcare experts conducted in 2020. The survey was performed using the “snowball ..."
 
Vol 16, No 2 (2023) Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients Abstract  similar documents
E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov
"... patients with moderate and severe CPS and a meta-analysis of randomized controlled trials, no differences ..."
 
Vol 5, No 2 (2012) COST EFFECTIVENESS OF ORAL PERICALCITOL IN PATIENTS WITH STAGE III-IV CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYREOSIS Abstract  similar documents
A. V. Rudakova
"... results of clinical trials demonstrate that selective vitamin D receptor agonist ..."
 
Vol 9, No 3 (2016) EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON Abstract  similar documents
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, D. V. Frolov, E. A. Ponomarev, A. S. Maslakov
"... et al. Results. The indirect comparison included 5 RCTs. Apixaban, rivaroxaban and dabigatran were ..."
 
Vol 18, No 2 (2025) Data analysis of medicines aimed at health technology assessment within the activities of the “Circle of Kindness” Foundation from 2021 to 2024 Abstract  similar documents
V. V. Omelyanovskiy, A. A. Kingshott, T. S. Teptsova, P. A. Mukhortova, A. G. Kharitonova, S. I. Zinadinov, L. O. Krekhtunova, N. A. Aldushchenko, A. А. Kozak, V. A. Ryagina
"... assessment was 12.00 months (interquartile range 5.52–35.94). Among study designs, randomized controlled ..."
 
Vol 5, No 2 (2012) METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES Abstract  similar documents
R. I. Yagudina, I. V. Sorokovikov
"... ) among studies of pharmacoeconomic analysis. Main stages of these trials are as follows: cost analysis ..."
 
Vol 14, No 3 (2021) Pharmacoeconomic aspects of COVID-19 treatment Abstract  similar documents
I. V. Rogova, E. A. Zhidkova, I. A. Popova, A. V. Zaborovskiy, K. G. Gurevich
"... coronavirus infection, separate groups of drugs are considered. The current clinical trials for COVID-19 ..."
 
Vol 18, No 1 (2025) The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market Abstract  similar documents
I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya
"... pharmacies in all federal districts of the RF for the period 2020–2023. In particular, the following ATС ..."
 
Vol 15, No 3 (2022) Funding for coronavirus health worker payments Abstract  similar documents
I. Yu. Bocharova, A. Yu. Rymanov
"... . Results. The regional distribution of transfers was regulated in 2020 by the Federal Government. The main ..."
 
Vol 13, No 3 (2020) The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation Abstract  similar documents
D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova
"... of the Government for 2019 and 2020. Materials and methods. The evaluation was performed by the methods ..."
 
Vol 17, No 4 (2024) The joint use of ABC/VEN analysis and the Beers criteria for optimizing expenditure of funds and rational prescribing of medications to elderly patients Abstract  similar documents
O. A. Makhmudova, G. F. Avkhadieva, O. G. Bagdanova, V. N. Khaziakhmetova
"... ; in 2020, this indicator was 10.6%; and in 2021, the costs for the procurements of drugs of N category ..."
 
Vol 6, No 4 (2013) Фармакоэкономический анализ использования лираглутида в составе комбинированной терапии в лечении сахарного диабета 2-го типа Abstract  similar documents
A. Yu. Kulikov, I. V. Novikov
"... with metformin, and metformin monotherapy. Methods: Data were sourced from a clinical trial comparing liraglutide ..."
 
Vol 10, No 3 (2017) Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis Abstract  similar documents
E. V. Biryukova, V. I. Ignat’eva
"... the federal healthcare budget. Materials and Methods. Based on the results of the DURABLE clinical trial, we ..."
 
Vol 14, No 3 (2021) Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital Abstract  similar documents
L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva
"... to May 2020. Based on the obtained results, a pharmacoeconomic assessment of the budgetary funds ..."
 
Vol 15, No 4 (2022) Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression Abstract  similar documents
D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin
"... deficiency. Material and methods. A retrospective controlled study was performed. The results of examining ..."
 
Vol 16, No 2 (2023) Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination Abstract  similar documents
I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova
"... for controlled ovarian stimulation in adult women to induce the growth of multiple follicles during cycles ..."
 
Vol 12, No 4 (2019) Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer Abstract  similar documents
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov
"... for the three-year period of 2020-2022. All patients who can be treated with palbociclib or ribociclib were ..."
 
Vol 8, No 1 (2015) PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION Abstract  similar documents
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach
"... and efficiency were taken from D. Cibrik et al. (2013) randomized control trial. We also estimated the budget ..."
 
Vol 18, No 1 (2025) Problems of using phenol (hydroxybenzene) and parabens as pharmaceutical stabilizers: analysis using machine learning methods Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... underline the need to conduct large-scale clinical trials on the long-term toxic effects of phenol ..."
 
Vol 15, No 2 (2022) Strengthening medical rehabilitation services in health system: a situation analysis Abstract  similar documents
D. V. Blinov, A. G. Solopova, L. N. Sandzhieva, E. E. Achkasov, D. I. Korabelnikov, D. M. Ampilogova, S. M. Khlopkova
"... of Health of the Russian Federation of June 31, 2020 No. 788n “Organization of medical rehabilitation ..."
 
Vol 16, No 4 (2023) Comparative chemomicrobiomic analysis of bacteriocins Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... . Material and methods. Chemomicrobiome analysis of bacteriocins A/B, C, S, 28b, RS-2020 was performed ..."
 
Vol 13, No 4 (2020) Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm Abstract  similar documents
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov
"... of biological therapy, and the use of glucocorticosteroids (GC)). Data from a prospective, historical controlled ..."
 
Vol 8, No 4 (2015) THE COST OF NUTRITION ALTERNATIVES FOR PREMATURE INFANTS IN RUSSIA Abstract  similar documents
K. V. Gerasimova, M. V. Avxentyeva, I. A. Belyaeva
"... the clinical trials. Besides we calculated the BM cost when BM fortifier is added for low-weight infants ..."
 
Vol 10, No 2 (2017) COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD Abstract  similar documents
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov
"... expenditures. Materials and methods. We used the available information from research, clinical trials ..."
 
Vol 11, No 2 (2018) Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov
"... and methods. Using the clinical trial data we developed a Markov model of CML progression on nilotinib ..."
 
Vol 11, No 3 (2018) Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review Abstract  similar documents
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin
"... with interferon β -1a. As evidenced by a randomized clinical trial, the annualized relapse rate estimated after 96 ..."
 
1 - 50 of 77 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)